PharmaShots Weekly Snapshots (December 19 - 23, 2022)
Outlook Therapeutics Reports EMA's Validation of MAA for ONS-5010 to Treat Wet AMD
Published: Dec 23, 2022 | Tags: Outlook Therapeutics, ONS-5010, Lytenava, bevacizumab, wet age-related macular degeneration, Regulatory, EMA, MAA
Published: Dec 23, 2022 | Tags: BridgeBio Pharma, Encaleret, Autosomal Dominant Hypocalcemia Type 1, Clinical Trial, P-III CALIBRATE Study
Published: Dec 23, 2022 | Tags: Genentech, Lunsumio, mosunetuzumab-axgb, Follicular Lymphoma, Regulatory, US, FDA, Approval
Published: Dec 23, 2022 | Tags: Merck, Mersana, Immunostimulatory, Antibody-Drug Conjugates, Immunosynthen STING-agonist platform, Biotech
Eli Lilly Expands its 2021 Agreement with ProQR Therapeutics for New Genetic Therapies
Published: Dec 23, 2022 | Tags: Eli Lilly, ProQr Therapeutics, New Genetic Therapies, Biotech, 2021, Axiomer technology
Published: Dec 23, 2022 | Tags: Merck, Antibody-drug Conjugate Candidates, Cancer, Biotech
Published: Dec 22, 2022 | Tags: CSL, Hemgenix, etranacogene dezaparvovec-drlb, Hemophilia B, Regulatory, US, FDA, Approval
Abbott’s Freestyle Libre 3 Combine with Automated Insulin Delivery System Mylife Loop in Germany
Published: Dec 22, 2022 | Tags: Abbott, Freestyle Libre 3 Integrated, Insulin Delivery System Mylife Loop, Germany
Published: Dec 22, 2022 | Tags: Everest Medicines, Pfizer, Etrasimod, Ulcerative Colitis, Regulatory, US, FDA, EMA
Published: Dec 22, 2022 | Tags: Mirati, Krazati, adagrasib, KRAS-Mutated Colorectal Cancer, Regulatory, US, FDA, Breakthrough Therapy Designation
Novan's EPI Health Entered into Exclusive License Agreement with Sato Pharma for Rhofade in Japan
Published: Dec 22, 2022 | Tags: EPI Health, Novan, Rhofade, Japan, Pharma
Jazz Pharmaceuticals Exercised its Option to Advance Zymeworks' Zanidatamab for Cancer Patients
Published: Dec 22, 2022 | Tags: Jazz Pharmaceutials, Zymeworks, Zanidatamab, Biliary Tract Cancers, Pharma
Published: Dec 21, 2022 | Tags: Sobi, ADC Therapeutics, Zynlonta, loncastuximab tesirine, Diffuse Large B-Cell Lymphoma, Regulatory, EC, Conditional Marketing Authorisation
Anzac Animal Health’s Zycosan Receives the US FDA’s Approval as First Injectable
Published: Dec 21, 2022 | Tags: Anzac Animal Health, Zycosan, pentosan polysulfate sodium injection, Equine Osteoarthritis, Regulatory, US, FDA, Approval
Published: Dec 21, 2022 | Tags: Altimmune, Pemvidutide, Non-Alcoholic Fatty Liver Disease, Clinical Trial,
Published: Dec 21, 2022 | Tags: Sosei Heptares, Pfizer, PF-07081532, Type 2 Diabetes, Obesity, Clinical Trial, P-II, Clinical Trial
Published: Dec 21, 2022 | Tags: Radius Health, Tymlos, abaloparatide, Osteoporosis, Regulatory, US, FDA, Approval
Published: Dec 21, 2022 | Tags: Verona Pharma, Ensifentrine, Chronic Obstructive Pulmonary Disease, Clinical Trial, P-III, ENHANCE-1 Trial
Published: Dec 20, 2022 | Tags: Atara Biotherapeutics, Ebvallo, tabelecleucel, Epstein‑Barr Virus Positive Post‑Transplant, Regulatory, EC, Approval
Published: Dec 20, 2022 | Tags: Abbott, Eterna Spinal Cord Stimulation System, Chronic Pain, Regulatory, US, FDA, Approval
Published: Dec 20, 2022 | Tags: Takeda, Maribavir, Cytomegalovirus Infection, Hematopoietic Stem Cell Transplant, Clinical Trial, P-III, AURORA Trial
Catalyst to Acquire Commercial Rights of Eisai’s Fycompa (perampanel) CIII in the US
Published: Dec 20, 2022 | Tags: Catalyst, Eisai, Fycompa, perampanel CIII, epileptic disorders, neurological diseases, Pharma
Published: Dec 20, 2022 | Tags: Gilead, Arcus, Domvanalimab, Non-Small Cell Lung Cancer, Clinical Trial, P-II, ARC-7 Study, ASCO, 2022
Sanofi Expands its 2016 Agreement with Innate Pharma for Natural Killer Cell Therapies in Oncology
Published: Dec 20, 2022 | Tags: Sanofi, Innate Pharma, Natural Killer Cell Therapies, Oncology, B7H3 ANKET, 2016, Biotech
Published: Dec 19, 2022 | Tags: Merck, GlenFeet Therapeutics, GFH925, Erbitux, cetuximab, Non-small cell lung cancer, Pharma
Dr. Reddy's Subsidiary Aurigene Stops Clinical Development of AUR-101 for the Treatment of Psoriasis
Published: Dec 19, 2022 | Tags: Dr Reddy, Aurigene, AUR-101, Psoriasis, Clinical Trial, P-IIb, INDUS-3 Trial,
Published: Dec 19, 2022 | Tags: Dr Reddy, CardiaCare, Digital Neuromodulation Wearable, Non-invasive Atrial Fibrillation, MedTech
Published: Dec 19, 2022 | Tags: Bionomics, BNC210, Social Anxiety Disorder, Clinical Trial, P-II, PREVAIL Study
Published: Dec 19, 2022 | Tags: AbbVie, Vraylar, cariprazine, Major Depressive Disorder, Regulatory, US, FDA, Approval
Published: Dec 19, 2022 | Tags: uniQure, Etranacogene Dezaparvovec, Hemophilia B, Regulatory, EMA, CHMP
Related Post: PharmaShots Weekly Snapshots (December 12 - 16, 2022)
Tags
Neha is a Senior Editor at PharmaShots. She is passionate and very enthusiastic about recent updates and developments in the life sciences and pharma industry. She covers Biopharma, MedTech, and Digital health segments along with different reports at PharmaShots. She can be contacted at connect@pharmashots.com.